The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 16, 2021
Filed:
Sep. 01, 2020
Applicant:
Orexo Ab, Uppsala, SE;
Inventor:
Andreas Fischer, Uppsala, SE;
Assignee:
OREXO AB, Uppsala, SE;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/485 (2006.01); A61K 9/14 (2006.01); A61K 9/20 (2006.01); A61K 9/00 (2006.01); A61K 31/4748 (2006.01);
U.S. Cl.
CPC ...
A61K 31/485 (2013.01); A61K 9/006 (2013.01); A61K 9/0056 (2013.01); A61K 9/14 (2013.01); A61K 9/20 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/2077 (2013.01); A61K 9/2095 (2013.01); A61K 31/4748 (2013.01);
Abstract
There is provided pharmaceutical compositions for the treatment of e.g. opioid dependency comprising microparticles of a pharmacologically-effective amount of buprenorphine, or a pharmaceutically-acceptable salt thereof, in associative admixture with particles comprising a weak acid, or particles comprising weakly-acidic buffer forming materials. The composition may further comprise a disintegrant and/or particles of a pharmacologically-effective amount of naloxone, or a pharmaceutically-acceptable salt thereof. The compositions are useful in the treatment of opioid dependency/addiction and/or pain.